Identification of Treatment Targets in a Genetic Mouse Model of Voluntary Methamphetamine Drinking

Tamara Phillips, J. R K Mootz, C. Reed

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Methamphetamine has powerful stimulant and euphoric effects that are experienced as rewarding and encourage use. Methamphetamine addiction is associated with debilitating illnesses, destroyed relationships, child neglect, violence, and crime; but after many years of research, broadly effective medications have not been identified. Individual differences that may impact not only risk for developing a methamphetamine use disorder but also affect treatment response have not been fully considered. Human studies have identified candidate genes that may be relevant, but lack of control over drug history, the common use or coabuse of multiple addictive drugs, and restrictions on the types of data that can be collected in humans are barriers to progress. To overcome some of these issues, a genetic animal model comprised of lines of mice selectively bred for high and low voluntary methamphetamine intake was developed to identify risk and protective alleles for methamphetamine consumption, and identify therapeutic targets. The mu opioid receptor gene was supported as a target for genes within a top-ranked transcription factor network associated with level of methamphetamine intake. In addition, mice that consume high levels of methamphetamine were found to possess a nonfunctional form of the trace amine-associated receptor 1 (TAAR1). The Taar1 gene is within a mouse chromosome 10 quantitative trait locus for methamphetamine consumption, and TAAR1 function determines sensitivity to aversive effects of methamphetamine that may curb intake. The genes, gene interaction partners, and protein products identified in this genetic mouse model represent treatment target candidates for methamphetamine addiction.

Original languageEnglish (US)
JournalInternational Review of Neurobiology
DOIs
StateAccepted/In press - 2016

Fingerprint

Methamphetamine
Genetic Models
Drinking
Genes
Chromosomes, Human, Pair 10
mu Opioid Receptor
Quantitative Trait Loci
Drug and Narcotic Control
Child Abuse
Crime
Violence
Individuality
Transcription Factors
Animal Models
History
Alleles

Keywords

  • Addiction
  • Aversion
  • Medication
  • Polymorphism
  • Quantitative trait locus
  • Reward
  • Selected lines
  • Therapeutic

ASJC Scopus subject areas

  • Clinical Neurology
  • Cellular and Molecular Neuroscience

Cite this

@article{a022a99ce40a4e9e9f57ff40c8ae4463,
title = "Identification of Treatment Targets in a Genetic Mouse Model of Voluntary Methamphetamine Drinking",
abstract = "Methamphetamine has powerful stimulant and euphoric effects that are experienced as rewarding and encourage use. Methamphetamine addiction is associated with debilitating illnesses, destroyed relationships, child neglect, violence, and crime; but after many years of research, broadly effective medications have not been identified. Individual differences that may impact not only risk for developing a methamphetamine use disorder but also affect treatment response have not been fully considered. Human studies have identified candidate genes that may be relevant, but lack of control over drug history, the common use or coabuse of multiple addictive drugs, and restrictions on the types of data that can be collected in humans are barriers to progress. To overcome some of these issues, a genetic animal model comprised of lines of mice selectively bred for high and low voluntary methamphetamine intake was developed to identify risk and protective alleles for methamphetamine consumption, and identify therapeutic targets. The mu opioid receptor gene was supported as a target for genes within a top-ranked transcription factor network associated with level of methamphetamine intake. In addition, mice that consume high levels of methamphetamine were found to possess a nonfunctional form of the trace amine-associated receptor 1 (TAAR1). The Taar1 gene is within a mouse chromosome 10 quantitative trait locus for methamphetamine consumption, and TAAR1 function determines sensitivity to aversive effects of methamphetamine that may curb intake. The genes, gene interaction partners, and protein products identified in this genetic mouse model represent treatment target candidates for methamphetamine addiction.",
keywords = "Addiction, Aversion, Medication, Polymorphism, Quantitative trait locus, Reward, Selected lines, Therapeutic",
author = "Tamara Phillips and Mootz, {J. R K} and C. Reed",
year = "2016",
doi = "10.1016/bs.irn.2016.02.001",
language = "English (US)",
journal = "International Review of Neurobiology",
issn = "0074-7742",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - Identification of Treatment Targets in a Genetic Mouse Model of Voluntary Methamphetamine Drinking

AU - Phillips, Tamara

AU - Mootz, J. R K

AU - Reed, C.

PY - 2016

Y1 - 2016

N2 - Methamphetamine has powerful stimulant and euphoric effects that are experienced as rewarding and encourage use. Methamphetamine addiction is associated with debilitating illnesses, destroyed relationships, child neglect, violence, and crime; but after many years of research, broadly effective medications have not been identified. Individual differences that may impact not only risk for developing a methamphetamine use disorder but also affect treatment response have not been fully considered. Human studies have identified candidate genes that may be relevant, but lack of control over drug history, the common use or coabuse of multiple addictive drugs, and restrictions on the types of data that can be collected in humans are barriers to progress. To overcome some of these issues, a genetic animal model comprised of lines of mice selectively bred for high and low voluntary methamphetamine intake was developed to identify risk and protective alleles for methamphetamine consumption, and identify therapeutic targets. The mu opioid receptor gene was supported as a target for genes within a top-ranked transcription factor network associated with level of methamphetamine intake. In addition, mice that consume high levels of methamphetamine were found to possess a nonfunctional form of the trace amine-associated receptor 1 (TAAR1). The Taar1 gene is within a mouse chromosome 10 quantitative trait locus for methamphetamine consumption, and TAAR1 function determines sensitivity to aversive effects of methamphetamine that may curb intake. The genes, gene interaction partners, and protein products identified in this genetic mouse model represent treatment target candidates for methamphetamine addiction.

AB - Methamphetamine has powerful stimulant and euphoric effects that are experienced as rewarding and encourage use. Methamphetamine addiction is associated with debilitating illnesses, destroyed relationships, child neglect, violence, and crime; but after many years of research, broadly effective medications have not been identified. Individual differences that may impact not only risk for developing a methamphetamine use disorder but also affect treatment response have not been fully considered. Human studies have identified candidate genes that may be relevant, but lack of control over drug history, the common use or coabuse of multiple addictive drugs, and restrictions on the types of data that can be collected in humans are barriers to progress. To overcome some of these issues, a genetic animal model comprised of lines of mice selectively bred for high and low voluntary methamphetamine intake was developed to identify risk and protective alleles for methamphetamine consumption, and identify therapeutic targets. The mu opioid receptor gene was supported as a target for genes within a top-ranked transcription factor network associated with level of methamphetamine intake. In addition, mice that consume high levels of methamphetamine were found to possess a nonfunctional form of the trace amine-associated receptor 1 (TAAR1). The Taar1 gene is within a mouse chromosome 10 quantitative trait locus for methamphetamine consumption, and TAAR1 function determines sensitivity to aversive effects of methamphetamine that may curb intake. The genes, gene interaction partners, and protein products identified in this genetic mouse model represent treatment target candidates for methamphetamine addiction.

KW - Addiction

KW - Aversion

KW - Medication

KW - Polymorphism

KW - Quantitative trait locus

KW - Reward

KW - Selected lines

KW - Therapeutic

UR - http://www.scopus.com/inward/record.url?scp=84959507709&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84959507709&partnerID=8YFLogxK

U2 - 10.1016/bs.irn.2016.02.001

DO - 10.1016/bs.irn.2016.02.001

M3 - Article

C2 - 27055611

AN - SCOPUS:84959507709

JO - International Review of Neurobiology

JF - International Review of Neurobiology

SN - 0074-7742

ER -